Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tamara Berno

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
Internal and Emergency Medicine|June 20, 2023
Light-chain cardiac amyloidosis for the non-expert: pearls and pitfallsLaura De Michieli, Giulio Sinigiani, Monica De Gaspari, et al.
Oncotarget|January 5, 2018
Bendamustine plus rituximab is an effective first-line treatment in hairy cell leukemia variant: a report of three casesAndrea Visentin, Silvia Imbergamo, Federica Frezzato, et al.
Neurology|August 19, 2016
Lenalidomide long-term neurotoxicity: Clinical and neurophysiologic prospective studyChiara Dalla Torre, Renato Zambello, Mario Cacciavillani, et al.
Journal of the Neurological Sciences|June 15, 2013
NK cells and their receptors in naive and rituximab-treated patients with anti-MAG polyneuropathyLuana Benedetti, Monica Facco, Diego Franciotta, et al.
International Journal of Cardiology|January 23, 2024
Hospitalization-based epidemiology of systemic and cardiac amyloidosis in the Veneto Region, ItalyLaura De Michieli, Giorgia Stoppa, Giulio Sinigiani, et al.
American Journal of Hematology|April 14, 2020
High rate of profound clonal and renal responses with daratumumab treatment in heavily pre-treated patients with light chain (AL) amyloidosis and high bone marrow plasma cell infiltratePaolo Milani, Francesca Fazio, Marco Basset, et al.
Anticancer Research|March 16, 2016
Bortezomib, Thalidomide and Lenalidomide: Have They Really Changed the Outcome of Multiple Myeloma?Michael Mian, Martina Tinelli, Elena DE March, et al.
Haematologica|September 7, 2014
Detection of monoclonal T populations in patients with KIR-restricted chronic lymphoproliferative disorder of NK cellsCristina Gattazzo, Antonella Teramo, Francesca Passeri, et al.
Journal of Cranio-Maxillo-Facial Surgery : Official Publication of the European Association for Cranio-Maxillo-Facial Surgery|April 2, 2019
Is vitamin D deficiency a risk factor for osteonecrosis of the jaw in patients with cancer? A matched case-control studyAlberto Bedogni, Giordana Bettini, Giorgio Bedogni, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|February 9, 2013
Could hypoxia increase the prevalence of thrombotic complications in polycythemia vera?Maurizio Zangari, Louis Fink, Giulia Tolomelli, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Internal and Emergency Medicine|June 20, 2023
Light-chain cardiac amyloidosis for the non-expert: pearls and pitfallsLaura De Michieli, Giulio Sinigiani, Monica De Gaspari, et al.
Oncotarget|January 5, 2018
Bendamustine plus rituximab is an effective first-line treatment in hairy cell leukemia variant: a report of three casesAndrea Visentin, Silvia Imbergamo, Federica Frezzato, et al.
Neurology|August 19, 2016
Lenalidomide long-term neurotoxicity: Clinical and neurophysiologic prospective studyChiara Dalla Torre, Renato Zambello, Mario Cacciavillani, et al.
Journal of the Neurological Sciences|June 15, 2013
NK cells and their receptors in naive and rituximab-treated patients with anti-MAG polyneuropathyLuana Benedetti, Monica Facco, Diego Franciotta, et al.
International Journal of Cardiology|January 23, 2024
Hospitalization-based epidemiology of systemic and cardiac amyloidosis in the Veneto Region, ItalyLaura De Michieli, Giorgia Stoppa, Giulio Sinigiani, et al.
American Journal of Hematology|April 14, 2020
High rate of profound clonal and renal responses with daratumumab treatment in heavily pre-treated patients with light chain (AL) amyloidosis and high bone marrow plasma cell infiltratePaolo Milani, Francesca Fazio, Marco Basset, et al.
Anticancer Research|March 16, 2016
Bortezomib, Thalidomide and Lenalidomide: Have They Really Changed the Outcome of Multiple Myeloma?Michael Mian, Martina Tinelli, Elena DE March, et al.
Haematologica|September 7, 2014
Detection of monoclonal T populations in patients with KIR-restricted chronic lymphoproliferative disorder of NK cellsCristina Gattazzo, Antonella Teramo, Francesca Passeri, et al.
Journal of Cranio-Maxillo-Facial Surgery : Official Publication of the European Association for Cranio-Maxillo-Facial Surgery|April 2, 2019
Is vitamin D deficiency a risk factor for osteonecrosis of the jaw in patients with cancer? A matched case-control studyAlberto Bedogni, Giordana Bettini, Giorgio Bedogni, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|February 9, 2013
Could hypoxia increase the prevalence of thrombotic complications in polycythemia vera?Maurizio Zangari, Louis Fink, Giulia Tolomelli, et al.
Pageof 3